SEBI Reg. Investment Advisor

Download App
Help Center Subscribe
Money Works 4 Me Logo MoneyWorks4Me
Talk to Advisor
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

Park Medi World Ltd (PARKHOSPS)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 544645 NSE: PARKHOSPS Hospital & Healthcare Services | Small Cap | Park Medi World Share Price

₹287.40 0.50 (0.17%)

As on 24-Jun'26 16:59

Park Medi World Ltd (PARKHOSPS)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 544645 NSE: PARKHOSPS Hospital & Healthcare Services | Small Cap | Park Medi World Share Price

₹287.40 0.50 (0.17%)

As on 24-Jun'26 16:59

Key Metrics
Valuation Multiples
Market Cap
₹12,414 Cr.
Current Price
₹287.4
52-Week Low / High
₹138 / 297
TTM EPS
₹0.9
TTM Sales
₹129 Cr.
Book Value per Share
₹19.9
P/E Ratio
339.02
Lower than its 5-year historical median
Industry PE
91.4
Price to Book (P/B)
14.43
Higher than its 5-year historical median
Price to Sales (P/S)
96.26
Higher than its 5-year historical median
EV/EBITDA
196.70
Lower than its 5-year historical median
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
6.51%
Underperforms industry median
Return on Capital Employed (ROCE)
8.47%
Underperforms industry median
Return on Assets (ROA)
2.42%
Operating Profit Margin
26.4%
Net Profit Margin
7.84%
Gross Profit Margin
15%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
2.26%
Operating Profit Growth (1 Year)
Slowing versus 3-year growth rate
-6.07%
Net Profit Growth (1 Year)
Improving versus 3-year growth rate
-4.27%
Asset Quality
Promoter Holding
82.89%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹774 Cr.
Equity
₹86.4 Cr.
Face Value
₹2
All Time Low / High
₹138.15 / 297.45

Park Medi World stock performance

Key Ratios
mw4me loader

Check Before You Invest

Check Before You Invest

Quality

Locked
Login to view analysis.

Valuation

Locked
Login to view analysis.

Price Trend

Locked
Login to view analysis.
Q.1 Is Park Medi World Ltd a good quality company?
Park Medi World Ltd is a weak quality company, based on a inconsistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

View More

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

View More
How does Park Medi World Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Park Medi World Ltd vs industry peers?
Park Medi World Ltd revenue CAGR is -5.91%, compared to the industry median CAGR of 6.53%, indicating slower growth and losing its market share.
Q.1 Promoter shareholding and pledge status of Park Medi World Ltd?
Promoters hold 82.89% of the Park Medi World Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Park Medi World Ltd over the last decade?
Over the last - year(s), the stock has delivered a CAGR of N/A% based on the current price.
View More

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Park Medi World Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation ⓘ

Mar'22Mar'23Mar'24Mar'25TTM
ROCE % ⓘ16.6%11.6%11.8%8.5%-
Value Creation
Index ⓘ		0.2-0.1-0.1-0.4-

Growth Parameters ⓘ
Sales ⓘ11010289.691.6129
Sales YoY Gr.--6.8%-12.6%2.3%-
Adj EPS ⓘ0.20.20.20.20.9
YoY Gr.--13.6%5.3%-5%-
BVPS (₹) ⓘ2.52.62.8319.9
Adj Net
Profit ⓘ		8.47.17.57.237
Cash Flow from Ops. ⓘ29.545.448.19.3-
Debt/CF from Ops. ⓘ3.32.52.617-

CAGR ⓘ

9 Years 5 Years 3 Years 1 Years
Sales ⓘNANA-5.9%2.3%
Adj EPS ⓘNANA-4.8%-5%
BVPSⓘNANA5.4%7.2%
Share Price - - - -

Key Financial Parameters ⓘ

Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity % ⓘ		8.67.27.36.67.4
Op. Profit
Mgn % ⓘ		18.823.428.826.429.6
Net Profit
Mgn % ⓘ		7.66.98.47.928.5
Debt to
Equity ⓘ		11.11.21.40
Working Cap
Days ⓘ		0294235178330
Cash Conv.
Cycle ⓘ		0843314158

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25
Sales1101029092
Operating Expenses ⓘ + 89786467
Manufacturing Costs2141716
Material Costs20191516
Employee Cost 15181617
Other Costs ⓘ 33381718
Operating Profit ⓘ 21242624
Operating Profit Margin (%) 18.8%23.4%28.7%26.4%
Other Income ⓘ + 15552
Exceptional Items ⓘ 0000
Interest ⓘ 20131412
Depreciation ⓘ 3555
Profit Before Tax ⓘ 1310139
Tax ⓘ 4352
Profit After Tax 8777
PAT Margin (%) 7.6%6.9%8.4%7.8%
Adjusted EPS (₹)0.20.20.20.2
Dividend Payout Ratio (%)0%0%0%0%

Valuation of Park Medi World - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 98100106114
Share Capital ⓘ 77777777
Reserves ⓘ 21243037
Debt +8899117145
Long Term Debt75353450
Short Term Debt13648394
Minority Interest0000
Trade Payables6101415
Others Liabilities ⓘ 37643944
Total Liabilities ⓘ 229273277317

Fixed Assets

Net Fixed Assets ⓘ +20347375
Gross Block44398289
Accumulated Depreciation245914
CWIP ⓘ 851337
Investments ⓘ 102148149149
Inventories0000
Trade Receivables44362233
Cash Equivalents 11946
Others Assets ⓘ 43421618
Total Assets ⓘ 229273277317

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity ⓘ + 3045489
PBT ⓘ 1310139
Adjustment ⓘ 10141521
Changes in Working Capital ⓘ 123024-20
Tax Paid ⓘ -5-9-3-0
Cash Flow From Investing Activity ⓘ + -21-39-51-31
Capex -191-51-33
Net Investments -15-42-51
Others ⓘ 13251
Cash Flow From Financing Activity ⓘ + -9-1-524
Net Proceeds from Shares ⓘ 0000
Net Proceeds from Borrowing ⓘ 19-40-721
Interest Paid ⓘ -20-13-14-7
Dividend Paid ⓘ 0000
Others ⓘ -853169
Net Cash Flow ⓘ -05-81

Financial Ratio

PARTICULARSMar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)8.557.187.256.51
ROCE (%)16.5711.5511.768.47
Asset Turnover Ratio0.480.410.330.31
PAT to CFO Conversion(x)3.756.436.861.29
Working Capital Days
Receivable Days147.50142.50117.60110.50
Inventory Days0.500.400.300.30
Payable Days114.30160.40299321.30

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Park Medi World Ltd FAQs

The current trading price of Park Medi World on 24-Jun-2026 16:59 is ₹287.4.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 23-Jun-2026 the market cap of Park Medi World stood at ₹12,413.7 Cr

The latest P/E ratio of Park Medi World as of 23-Jun-2026 is 339.0.

The latest P/B ratio of Park Medi World as of 23-Jun-2026 is 14.43.

The 52-week high of Park Medi World is ₹297.4 and the 52-week low is ₹138.2.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Park Medi World is ₹129 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Park Medi World Ltd is a below average quality company.

The key valuation ratios of Park Medi World Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Park Medi World Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

About Park Medi World Ltd

Park Medi World was incorporated in New Delhi as ‘Park Medi World Private Limited’ as a private limited company on January 20, 2011. Subsequently, the company was converted to a public limited company and the name of the company has been changed to the present name, ‘Park Medi World Limited’, pursuant to a resolution passed by the board on November 15, 2024 and by the shareholders on November 18, 2024.

The company is one of the largest private hospital chains in North India. It offers multiple super specialty and specialty services, including internal medicine, neurology, urology, gastroentereology, general surgery, orthopedics and oncology. It operates a network of NABH accredited multi-super specialty hospitals under the ‘Park’ brand, of which some hospitals are also NABL accredited. The company has adopted a cluster-based approach to grow its network of hospitals leveraging the benefits of proximity between its hospitals leading to operational efficiencies and enabling it to benefit from economies of scale.

In order to ensure that its services remain affordable, the company actively pursue several strategic measures to manage its operating costs. These include employing modern medical technology to reduce recovery time, employing full-time doctors and consultants, nurses and medical staff, maintaining strong relationships with its vendors and leveraging economies of scale from its existing network. The company is led by its founder and Chairman Ajit Gupta, whose leadership and deep understanding of the healthcare landscape in India has laid the foundation for the company’s growth.

Business area of the company 

The company, along with its subsidiaries, is in the business of owning, managing and running medical facilities in order to provide comprehensive services and to undertake research including clinical research and development work required to promote, assist or engage in setting up hospitals.

Services of the company

  • Internal Medicine
  • Neurology
  • Urology
  • Gastroenterology
  • Cardiology
  • General Surgery
  • Orthopedic
  • Oncology
  • Other specialty service

Awards, accreditations and recognition 

  • 2017: Indian Excellence Award for ‘Best Multi-Specialty Hospital in Delhi-NCR and Haryana’ in ‘Healthcare & Business Sector’ was awarded to Park Hospital.
  • 2019: Healthcare Leadership Award for ‘Best Multi Super Speciality Hospital’ was awarded to Park Hospital, Gurgaon.
  • 2019: Award for ‘Most Valuable and Admirable Hospital’ was awarded to Park group of Hospitals by ET Now.

History and milestones

  • 2011: Incorporation of the company on January 20, 2011.
  • 2011:  Took over the running proprietorship business of Park Sunil Hospital, Delhi and/or Park Hospital, New Delhi from one of the Promoters, Ajit Gupta.
  • 2011: The company acquired Aggarwal Hospitals and Research Services Private Limited.
  • 2017: The company’s subsidiary, Park Medicenters acquired DMR Hospitals Private Limited.
  • 2020: The company acquired Blue Heavens Health Care Private Limited.
  • 2020: The company’s subsidiary, Kailash Super-Speciality Hospital Private Limited acquired 100% running business of ‘Kailash Hospital Behror’.
  • 2021: The company acquired Umkal Health Care Private Limited.
  • 2021: The company’s subsidiary, Park Medicity India Private Limited acquired Narsingh Hospital & Heart Institute Private Limited.
  • 2022: The company’s subsidiary, Park Medicenters & Institutions Private Limited acquired Ratangiri Innovations Private Limited.
  • 2023: The company’s subsidiary, Park Medicenters & Institutions Private Limited acquired R G S Healthcare Limited.
  • 2025: The company’s subsidiary, Aggarwal Hospitals and Research Services Private Limited acquired 55.00% share capital Devina Derma Private Limited.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: